2-Bromopyrimidine-5-carboxylic acid, 95.0%, 250mg

9,9-Bis(4-amino-3-chlorophenyl)fluorene, 97%, 10g

Monomethacryloxypropylterminated polydimethylsiloxane - asymmetric cSt 150-200 inhibited with BHT, 100g

3-Furan-2-yl-3-oxo-propionic acid ethyl ester, 95.0%, 5g

Palladium (II) chloride, 99.0%, 5g

(3S,4S,5R)-5-((S)-1,2-Dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-one, 1g

N,N-Diethyl-2-hydroxyacetamide, 95.0%, 5g

METHYL 6-CHLORO-3-(4-(TRIFLUOROMETHYL)PHENYL)PICOLINATE, 95.0%, 100mg

ETHYL 2-DEOXY-2-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOL-2-YL)-1-THIO-BETA-D-GLUCOPYRANOSIDE, 95%, 5g

3,8-Dibromo-1,10-phenanthroline-5,6-dione, 97.0%, 250mg

3-Acetamidophenylboronic Acid (contains varying amounts of Anhydride)1g

9-(2-Bromophenyl)phenanthrene, 97%, 250mg

8-tert-butyl-4-(thiophene-2-carbonyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g